Roche Genentech:Our Approach

Our Approach

Our Approach

In2009,GenentechbecameamemberoftheRochegroupandtheheadquartersforRochepharmaceuticaloperationsintheUnitedStates.。其他文章還包含有:「AboutUs」、「Genentech」、「GenentechR&D(gRED)」、「OurPipeline」、「Visitus」、「基因泰克」、「羅氏集團」

查看更多 離開網站

Provide From Google
About Us
About Us

https://www.gene.com

Genentech became a member of the Roche Group in March of 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical ...

Provide From Google
Genentech
Genentech

https://www.gene.com

Breakthrough science. One moment, one day, one person at a time.

Provide From Google
Genentech R&D (gRED)
Genentech R&D (gRED)

https://www.roche.com

Genentech is a leading biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life- ...

Provide From Google
Our Pipeline
Our Pipeline

https://www.gene.com

Oncology; Immunology; Neuroscience; Metabolism; Infectious Disease; Ophthalmology; Other; Managed by Roche. Phase I Phase II Phase III. Molecule. Phase.

Provide From Google
Visit us
Visit us

https://www.gene.com

Following our March 2009 merger with Roche, Genentech's South San Francisco campus became the headquarters for Roche pharmaceutical operations in the United ...

Provide From Google
基因泰克
基因泰克

https://zh.wikipedia.org

基因泰克公司(英語:Genentech Inc.),全名基因工程科技公司(英語:Genetic ... 羅氏藥廠於2009年3月26日以大約468億美元完成了基因泰克的收購,並完全擁有此公司。

Provide From Google
羅氏集團
羅氏集團

https://www.roche.com.tw

羅氏是全球最大的生物科技公司,擁有在癌症、免疫、感染性疾病、眼科及中樞神經系統等領域的獨特藥品。羅氏也在體外診斷、癌症組織診斷居於世界領導地位,並在糖尿病管理 ...